Document Type : Case Report(s)
Authors
1 Department of Pediatric Surgery, Maryam Hospital, Alborz University of Medical Sciences, Karaj, Iran
2 Department of Epidemiology, Alborz University of Medical Sciences, Karaj, Iran
3 Deputy of Health, Alborz University of Medical Sciences, Karaj, Iran
4 Department of Pathology, Fardis central Laboratory, Alborz University of Medical Sciences, Karaj, Iran
Abstract
Yolk sac tumors (YSTs) of the ovary are rare neoplasms, accounting for less than 0.2% of all ovarian tumors. Although this malignancy is much rarer in children, pediatric cases are attributed to a poorer prognosis. Diagnosis of YST is often made by post-operative pathologic examination. The prevalent clinical presentations include fever, distended abdomen or asymptomatic abdominal mass. YST rarely coexists with involvement of fallopian tube and this entity is rare in children.
The present research was conducted to present a rare case of ovarian YST in an 8-month-old female infant with involvement of fallopian tube. This report, presents a rare case of YST in terms of its clinical presentation, histopathology findings, imaging findings, diagnosis, and treatment. The patient underwent surgical resection of the mass, followed by pathological examination, which confirmed an ovarian YST. To the best of our knowledge, this case is the youngest case of ovarian YST with the involvement of the fallopian tube reported in literature.
Keywords
How to cite this article:
Delshad S, Piri N, Sharifi F, Mirmoghadam Z. Ovarian yolk sac tumor coexisting with the involvement of the fallopian tube in an eight-month-old girl: a rare case report. Middle East J Cancer. 2022;13(4):717-22. doi: 10.30476/mejc.2021.89096. 1505.
2.Taskinen S, Fagerholm R, Lohi J, Taskinen M. Pediatric ovarian neoplastic tumors: incidence, age at presentation, tumor markers and outcome. Acta Obstet Gynecol Scand. 2015;94(4):425-9. doi: 10.1111/aogs. 12598.
3.Trott P. International classification of diseases for oncology. J Clin Pathol. 1977;30(8):782. doi: 10.1136/jcp.30.8.782-c.
4.de La Motte Rouge T, Pautier P, Rey A, Duvillard P, Kerbrat P, Troalen F, et al. Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases. Eur J Cancer. 2011;47(2):175-82. doi: 10.1016/j.ejca.2010.08.012.
5.Saksela E. Immunohistochemical markers of yolk sac tumors. In: Francisco F, editor. The Human yolk sac and yolk sac tumors. 1st ed. Berline: Springer; 1993. p. 216-27.
6.He Y, Lu H, Zhang L. Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases. Prog Mol Biol Transl Sci. 2019;162:199-212. doi: 10.1016/bs.pmbts.2019.01.001.
7.Eddaoualline H, Sami H, Rais H, Belbaraka R, El Omrani A, Khouchani M. Ovarian yolk sac tumor: a case report and literature review. Clin Case Rep Int. 2018; 2:1057.
8.Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976;38(6):2404-19. doi: 10.1002/1097-0142(197612)38:6<2404::aid-cncr2820380629>3.0.co;2-3.
9.Chen LH, Yip KC, Wu HJ, Yong SB. Yolk Sac Tumor in an eight-year-old girl: A case report and literature review. Front Pediatr. 2019;7:169. doi: 10.3389/ fped.2019.00169.
10.Mahadik K, Ghorpade K. Childhood ovarian malignancy. J Obstet Gynaecol India. 2014;64(2):91-4. doi: 10.1007/s13224-014-0533-4.
11. Prat J; FIGO Committee on Gynecologic Oncology. FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015;26(2):87-9. doi: 10.3802/ jgo.2015.26.2.87.
12.Anfelter P, Testa A, Chiappa V, Froyman W, Fruscio R, Guerriero S, et al. Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors). Ultrasound Obstet Gynecol. 2020;56(2):276-84. doi: 10.1002/uog. 22002. Erratum in: Ultrasound Obstet Gynecol. 2020;56(6):966.
13.Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Holcomb K. Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecol Oncol. 2017;147(2):296-301. doi: 10.1016/j.ygyno.2017.08.013.
)